Cargando…
Crizotinib Associated Renal Cysts [CARCs]: incidence and patterns of evolution
BACKGROUND: Novel therapeutic agents recently introduced for the treatment of cancer have several unusual side effects. An increased incidence of renal cystic lesions, often with features concerning for malignancy or infection, has been reported in patients with anaplastic lymphoma kinase (ALK) - re...
Autores principales: | Cameron, Laird B, Jiang, Damian H S, Moodie, Kate, Mitchell, Catherine, Solomon, Benjamin, Parameswaran, Bimal Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314638/ https://www.ncbi.nlm.nih.gov/pubmed/28209203 http://dx.doi.org/10.1186/s40644-017-0109-5 |
Ejemplares similares
-
Complex renal cysts associated with crizotinib treatment
por: Schnell, Patrick, et al.
Publicado: (2015) -
Alectinib Induced Regression of Renal and Hepatic Cysts Caused by Crizotinib
por: Di Marino, Pietro, et al.
Publicado: (2020) -
Korean Cardiac Arrest Research Consortium (KoCARC): rationale, development, and implementation
por: Kim, Joo Yeong, et al.
Publicado: (2018) -
DeepCarc: Deep Learning-Powered Carcinogenicity Prediction Using Model-Level Representation
por: Li, Ting, et al.
Publicado: (2021) -
Optimising structural imaging of neuroendocrine tumours in the molecular imaging age
por: Parameswaran, Bimal Kumar, et al.
Publicado: (2014)